🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II pilot trial studies how well ruxolitinib phosphate and danazo...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2013-04
Trial ID
NCT01732445
Treatments Being Tested
This is a Phase II investigator-Initiated trial of the Investigational Drug...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2012-04
Trial ID
NCT01594216
Treatments Being Tested
The purpose of the study is to identify the recommended Part 2 dose (R2PD) ...
Status
Active Not Recruiting
Location
City of Hope
Start Date
2022-05-04
Trial ID
NCT05371964
Treatments Being Tested
The purpose of this study is to compare the safety and effects of ruxolitin...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2019-05-14
Trial ID
NCT03954236
Treatments Being Tested
Myelofibrosis (MF) is a bone marrow illness that affects blood-forming tiss...
Status
Active Not Recruiting
Location
University of California, Davis Comprehensive Cancer Center /ID# 221790
Start Date
2020-11-11
Trial ID
NCT04454658
Treatments Being Tested
The purpose of this phase Ib/II clinical trial was to: a) evaluate the safe...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-05-08
Trial ID
NCT01787552
This phase II trial tests whether ruxolitinib works to shrink tumors in pat...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2023-05-03
Trial ID
NCT05592015
Treatments Being Tested
This phase II trial studies how well administering ruxolitinib before, duri...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2020-12-18
Trial ID
NCT04384692
Treatments Being Tested
This phase II trial studies how well ruxolitinib works in treating patients...
Status
Recruiting
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-11-15
Trial ID
NCT03801434
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of ruxolit...
Status
Withdrawn
Location
University of Alabama Hospital
Start Date
2023-01-31
Trial ID
NCT05233410
Treatments Being Tested